Methiodal
Chemical compound
- V08AA09 (WHO)
- Sodium iodomethanesulfonate
- 143-47-5
Y
- Sodium salt: 126-31-8
Y
- 23662381
- DB13321
Y
- 29078
- H20847G0I0
- Sodium salt: 3880P18UBM
Y
- D09213
- DTXSID701035794
![Edit this at Wikidata](http://upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)
- Interactive image
- C(S(=O)(=O)[O-])I.[Na+]
InChI
- InChI=1S/CH3IO3S.Na/c2-1-6(3,4)5;/h1H2,(H,3,4,5);/q;+1/p-1
- Key:COCJIVDXXCJXND-UHFFFAOYSA-M
Methiodal is a pharmaceutical drug that was used as an iodinated contrast medium for X-ray imaging.[1] Its uses included myelography (imaging of the spinal cord); for this use, cases of adhesive arachnoiditis have been reported, similar to those seen under the contrast medium iofendylate.[2]
It is not known to be marketed anywhere in the world in 2021.[3]
References
- ^ Vällfors B, Hansson HA, Belghmaïdi M, Irstam L, Persson LI (September 1983). "Effect of radiologic contrast media and local anaesthetics on the blood-brain barrier and on the leptomeninges". Acta Neurologica Scandinavica. 68 (3): 164–70. doi:10.1111/j.1600-0404.1983.tb05343.x. PMID 6316706. S2CID 45152412.
- ^ Skalpe IO (March 1978). "Adhesive arachnoiditis following lumbar myelography". Spine. 3 (1): 61–4. doi:10.1097/00007632-197803000-00012. PMID 205956. S2CID 23788810.
- ^ "Methiodal search results". Drugs.com. Retrieved 2021-03-31.
- v
- t
- e
Iodinated, Water soluble |
| ||||||
---|---|---|---|---|---|---|---|
Iodinated, Water insoluble |
| ||||||
Non-iodinated |
Paramagnetic | |
---|---|
Superparamagnetic |
|
Other |
- Microspheres of human albumin
- Microparticles of galactose
- Perflenapent
- Microspheres of phospholipids
- Sulfur hexafluoride
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
![]() | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e